Post- versus presynaptic plasticity in L-DOPA-induced dyskinesia.
about
Presynaptic Mechanisms of l-DOPA-Induced Dyskinesia: The Findings, the Debate, and the Therapeutic ImplicationsMultiple roles for nicotine in Parkinson's diseaseStriatal Plasticity in L-DOPA- and Graft-Induced Dyskinesia; The Common Link?Functional neuroimaging in Parkinson's diseaseA53T-alpha-synuclein overexpression impairs dopamine signaling and striatal synaptic plasticity in old micePSD-95 expression controls L-DOPA dyskinesia through dopamine D1 receptor traffickingCell type-specific plasticity of striatal projection neurons in parkinsonism and L-DOPA-induced dyskinesia.Proteomic analysis of striatal proteins in the rat model of L-DOPA-induced dyskinesia.Presynaptic dopaminergic compartment determines the susceptibility to L-DOPA-induced dyskinesia in ratsInhibition of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) signaling in the striatum reverts motor symptoms associated with L-dopa-induced dyskinesia.Effects of noradrenergic denervation by anti-DBH-saporin on behavioral responsivity to L-DOPA in the hemi-parkinsonian rat.The acute brain response to levodopa heralds dyskinesias in Parkinson disease.Maladaptive striatal plasticity in L-DOPA-induced dyskinesia.Spontaneous locomotor activity and L-DOPA-induced dyskinesia are not linked in 6-OHDA parkinsonian rats.Extrastriatal dopaminergic circuits of the Basal Ganglia.Effects of levodopa on regional cerebral metabolism and blood flowPresynaptic effects of levodopa and their possible role in dyskinesia.L-Dihydroxyphenylalanine modulates the steady-state expression of mouse striatal tyrosine hydroxylase, aromatic L-amino acid decarboxylase, dopamine and its metabolites in an MPTP mouse model of Parkinson's diseaseA Genetic Mouse Model of Parkinson's Disease Shows Involuntary Movements and Increased Postsynaptic Sensitivity to Apomorphine.Imbalanced Dopaminergic Transmission Mediated by Serotonergic Neurons in L-DOPA-Induced Dyskinesia.Sensorimotor connectivity in Parkinson's disease: the role of functional neuroimagingNicotine and Parkinson's disease: implications for therapy.The cannabinoid agonist WIN55212-2 decreases L-DOPA-induced PKA activation and dyskinetic behavior in 6-OHDA-treated ratsAbnormal dopaminergic modulation of striato-cortical networks underlies levodopa-induced dyskinesias in humans.Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: role of CB(1) and TRPV1 receptors.Reduced vesicular monoamine transport disrupts serotonin signaling but does not cause serotonergic degenerationMultisite intracerebral microdialysis to study the mechanism of L-DOPA induced dopamine and serotonin release in the parkinsonian brainThe role of the dorsal raphe nucleus in the development, expression, and treatment of L-dopa-induced dyskinesia in hemiparkinsonian rats.Maladaptive Synaptic Plasticity in L-DOPA-Induced DyskinesiaTargeting nicotinic receptors for Parkinson's disease therapy.Mechanisms underlying the onset and expression of levodopa-induced dyskinesia and their pharmacological manipulation.Contribution of serotonergic transmission to the motor and cognitive effects of high-frequency stimulation of the subthalamic nucleus or levodopa in Parkinson's disease.Targeting glutamate receptors to tackle the pathogenesis, clinical symptoms and levodopa-induced dyskinesia associated with Parkinson's disease.Levodopa-induced dyskinesias in Parkinson's disease: emerging treatmentsTherapeutic potential of targeting glutamate receptors in Parkinson's disease.Emerging drugs for levodopa-induced dyskinesia.Pharmacological strategies for the management of levodopa-induced dyskinesia in patients with Parkinson's disease.mGlu5, Dopamine D2 and Adenosine A2A Receptors in L-DOPA-induced Dyskinesias.l-DOPA-induced dyskinesia in Parkinson's disease: Are neuroinflammation and astrocytes key elements?Aberrant CpG Methylation Mediates Abnormal Transcription of MAO-A Induced by Acute and Chronic L-3,4-Dihydroxyphenylalanine Administration in SH-SY5Y Neuronal Cells.
P2860
Q21129423-6CD9EA7F-771F-4E11-8AE5-02ABB4869F26Q22252514-140AE6BC-9B7B-45E6-BAD4-2E491BECD638Q26768220-33D53EE4-C7B9-419B-8CD5-76FEB990DBC3Q27013767-D189A63E-47CE-47A2-B67B-9EB612974F53Q27324171-5C4B2C79-77A0-47CE-AC52-F53476ABA12DQ28582674-729F9568-B35E-48AD-9FF8-0DA5ADA22934Q30650489-FEC4EEC1-01D7-44FC-ACE7-97CF5F0137EAQ33285975-9979BF2A-7559-445F-B7B8-DB9FD0BB12BAQ33628372-AC06AA92-D0CB-488D-BF52-A283A07C8040Q33758221-6D9C5A15-0D9A-4C07-ADF1-5743BDB6293DQ33918393-D8BA517F-9F87-4BCA-9F1C-BA43D6D3A52CQ33957877-2DC0B7CA-AC44-4961-B8F8-9B311EB436E3Q34094008-B142F676-914F-4681-9C58-154CA78802DCQ34279877-2038A498-5D19-4D75-85E9-6A557C5F85BAQ34330022-CC6388D9-39E5-4A2A-AD98-B0137E6E5556Q35040119-BB5915E3-A7DE-4535-8265-5F195F5F886FQ35040280-7FB4D9BA-9EFC-440F-9167-BBF3A4BF444EQ35291721-263F9D54-FB72-453D-A78F-B269B3CB6747Q35324207-6905508C-1526-48B8-8621-273262AAD3E5Q35324977-FE0852DB-A3CF-4C5E-90FA-62B23390E775Q35325681-E1F301B0-7E5B-45B7-B6D0-3057BA60DBA9Q35601652-3E49AF33-0818-4C82-977B-136D83885513Q35740152-4C47B780-FFD8-4EF0-9830-B0E64898AE05Q36186759-F5D26D1D-5A52-48D6-A804-CDB3CDC73809Q36248857-FF236F3E-8A30-471A-B2AB-E583238988B2Q36691830-875A0F99-9910-4EF1-B177-5832AF3D7BBFQ36851713-0E589524-66DA-402A-8F2A-71A99F5F8266Q37341623-8893FB74-2C6E-4D03-9B73-2F3BA24141C5Q37516434-2441A248-9E25-43D5-AA85-F2A57C9327C4Q37916643-8BAF040A-B1B7-49FE-9349-C0AB850A4A3BQ37924629-38B0A8CE-9BD0-4748-983E-954D393F4A5DQ37973611-25D2CA68-F9E9-4350-B9F9-BF96D79A3C82Q38056852-461DA7FE-9056-4560-BC61-44646ED28892Q38156760-8BC59391-6E4E-49EE-9FC1-401781A79808Q38190016-B8BBF33B-EAA5-4071-891E-588639CD9D51Q38242091-709B53A3-78EB-440F-B597-EDCF1ABF30BDQ38262418-0CBFC13D-4ED6-4AB0-96CE-9E90AE17A8BAQ38660240-9C76A583-AC54-4CB2-822A-2CFF8A7E70E9Q38951947-8BAA3BD8-8F04-4A8E-A801-56F07F423D50Q39096105-A4458B8C-5C21-42D8-8B5B-CB08C5CF05C7
P2860
Post- versus presynaptic plasticity in L-DOPA-induced dyskinesia.
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Post- versus presynaptic plasticity in L-DOPA-induced dyskinesia.
@ast
Post- versus presynaptic plasticity in L-DOPA-induced dyskinesia.
@en
Post- versus presynaptic plasticity in L-DOPA-induced dyskinesia.
@nl
type
label
Post- versus presynaptic plasticity in L-DOPA-induced dyskinesia.
@ast
Post- versus presynaptic plasticity in L-DOPA-induced dyskinesia.
@en
Post- versus presynaptic plasticity in L-DOPA-induced dyskinesia.
@nl
prefLabel
Post- versus presynaptic plasticity in L-DOPA-induced dyskinesia.
@ast
Post- versus presynaptic plasticity in L-DOPA-induced dyskinesia.
@en
Post- versus presynaptic plasticity in L-DOPA-induced dyskinesia.
@nl
P2860
P1476
Post- versus presynaptic plasticity in L-DOPA-induced dyskinesia.
@en
P2093
M Angela Cenci
Martin Lundblad
P2860
P304
P356
10.1111/J.1471-4159.2006.04124.X
P407
P577
2006-08-29T00:00:00Z